---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-095236"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:49:31.026994+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA Pharma: two directors resign; Julie O'Neill appointed Non-Executive Chair

## Summary
- Jan van de Winkel and Tim Reilly resign effective Aug 30, 2024, citing increased time commitments from other roles.
- Julie O'Neill appointed Non-Executive Chair; Board reduced from 6 to 5 members.
- Board reclassified into three classes; O'Neill reappointed as Class I director, term expiring at 2026 Annual Meeting.
- Audit Committee: Cassidy (Chair), Kaufman, O'Neill; Compensation: O'Neill (Chair), Cassidy; Nominating: Kaufman (Chair), Cassidy.
- Resignations not due to any disagreement with Company's operations, policies, or practices.

## SEC filing metadata
- accession: 0001104659-24-095236
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/tm2423083d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-095236
- JSON: https://secwatch.observer/filing/0001104659-24-095236.json
- Plain text: https://secwatch.observer/filing/0001104659-24-095236.txt

## Key facts
- Executive change
  Julie O'Neill was appointed as non-executive chair at HOOKIPA Pharma Inc..
  - Action: appointed
  - Role: non-executive chair
  source text: the Company’s board of directors (the “Board”) appointed Julie O’Neill to serve as non-executive chair of the Board, effective as of the Effective Time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm
- Executive change
  Jan van de Winkel resigned as director at HOOKIPA Pharma Inc..
  - Action: resigned
  - Role: director
  source text: On August 27, 2024, Jan van de Winkel, Ph.D., notified HOOKIPA Pharma Inc. (the “Company”) of his resignation as a director of the Company, effective as of August 30, 2024 at 12:00 p.m. Eastern Time
  evidence_url: https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm
- Executive change
  Timothy Reilly resigned as director at HOOKIPA Pharma Inc..
  - Action: resigned
  - Role: director
  source text: On August 27, 2024, Timothy Reilly, Ph.D., notified the Company of his resignation as a director of the Company, effective as of the Effective Time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1760542/000110465924095236/0001104659-24-095236-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.